CASI Pharmaceuticals, Inc. Gains 51.16%
Mon, Aug 04, 2025 at 07:01 PM
CASI Pharmaceuticals, Inc. (CASI:NASDAQ) soared at $1.95, representing a gain of 51.2%. On Mon, Aug 04, 2025, CASI:NASDAQ hit a New 2-Week High of $1.95. The stock appeared on our News Catalysts scanner on Mon, Aug 04, 2025 at 11:47 AM in the 'BIOTECH' category. From Mon, Jul 21, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Mon, Aug 04, 2025 at $2.57 with a volume of 63M+.
About CASI Pharmaceuticals, Inc. (CASI:NASDAQ)
CASI Pharmaceuticals Inc is engaged in research and development of biopharmaceutical products. It mainly focuses on acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs.
Top 10 Gainers:
- Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
- Verb Technology Company, Inc. (VERB:NASDAQ), 114.27%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 92.37%
- CommScope Holding Company, Inc. (COMM:NASDAQ), 86.26%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 85.4%
- Steelcase Inc. (SCS:NYSE), 62.87%
- Earlyworks Co., Ltd (ELWS:NASDAQ), 52.56%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 51.16%
- Lichen International Limited (LICN:NASDAQ), 48.03%
- ATA Creativity Global (AACG:NASDAQ), 36.11%